Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Melatonin implants and long daylight hours alter the timing of hormone release and hair growth in mouflon sheep.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.